Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Chaga mushrooms contain compounds that may promote hair growth better than common treatments.

Applying EGCG on the skin can prevent hair loss caused by testosterone in mice.

Antiandrogen therapy helps treat genetic hair loss.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

Androgens like testosterone may help treat traumatic brain injury by reducing mitochondrial stress and inflammation.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

Increased PPARGC1α relates to hair thinning in common baldness.

Men with more CAG repeats in the androgen receptor gene and lower testosterone levels may experience more severe COVID-19.

Some alopecia treatments might help treat COVID-19, but more research is needed.

The over-the-counter supplement DHEA could make COVID-19 worse, especially in diabetics and people with G6PD deficiency.

Serum biomarkers like insulin-like growth factor-1 and vitamin D may help diagnose androgenetic alopecia.

Jagged1 and Epidermal Growth Factor together significantly increased hair growth in mice with androgen-suppressed hair.

Analog 23 is a promising compound for prostate cancer treatment.

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

Men with certain types of baldness at age 45 may have a higher risk of colon cancer and colorectal adenoma.

LC-MS/MS is more reliable than immunoassays for diagnosing 21-hydroxylase deficiency.

Male pattern baldness is linked to higher levels of a certain receptor in the scalp, which leads to the shrinking of blood vessels and hair loss. Early treatment targeting this receptor could be more effective.

Most women with hirsutism have it because of PCOS, and they need long-term treatment including medication and hair removal to improve their condition.

The document concludes that combination therapy is most effective for treating excessive hair growth in women with idiopathic hirsutism, and more research is needed to understand the condition.

Clascoterone may be a promising treatment for hair loss.

Hormonal therapies are safe and effective for treating acne in female adolescents, with specific treatments for those with endocrine disorders.

Genetic defects in testosterone production can cause hormonal and developmental disorders, and more research is needed to understand androgen regulation and develop safer treatments.

5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.

The conclusion is that hair loss in women is caused by a mix of hormonal, environmental, and genetic factors, and treatments should target these various causes.

A woman with anorexia and Cushing's syndrome improved after tumor removal, highlighting the need to consider hormonal issues in psychiatric conditions.

Paxillin may help manage androgen-related disorders like PCOS by stabilizing androgen receptor proteins.

A new treatment called SAMiRNA-AR68 increases hair count in people with hair loss, showing similar results to existing treatments but without side effects.

Aging men face unique health issues like erectile dysfunction, prostate problems, and baldness.

Purple corn extract may help reduce prostate enlargement and inflammation.